PHASE IB DOSE-ESCALATION STUDY OF BEZ235 OR BKM120 IN COMBINATION WITH PACLITAXEL (PTX) IN PATIENTS WITH ADVANCED SOLID TUMORS

被引:0
|
作者
Dirix, L. [1 ]
Schuler, M. [2 ]
Machiels, J. [3 ]
Hess, D. [4 ]
Awada, A. [5 ]
Steeghs, N. [6 ]
Paz-Ares, L. [7 ]
von Moos, R. [8 ]
Rabault, B. [9 ]
Rodon, J. [10 ]
机构
[1] Sint Augustinus Hosp, Antwerp, Belgium
[2] Univ Klinikum Essen, Westdeutsch Tumorzentrum, Essen, Germany
[3] Clin Univ St Luc, Dept Med Oncol, B-1200 Brussels, Belgium
[4] Kantonsspital St Gallen, St Gallen, Switzerland
[5] Inst Jules Bordet, Dept Med Oncol, B-1000 Brussels, Belgium
[6] Netherlands Canc Inst, Amsterdam, Netherlands
[7] Univ Hosp Virgen del Rocio, Seville, Spain
[8] Kantonsspital Graubunden, Chur, Switzerland
[9] Novartis Pharma AG, Oncol, Basel, Switzerland
[10] Vall dHebron Univ Hosp, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:157 / 158
页数:2
相关论文
共 50 条
  • [31] A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors
    Patricia M. LoRusso
    Jeffrey R. Infante
    Kevin B. Kim
    Howard A. Burris
    Gregory Curt
    Ugochi Emeribe
    Delyth Clemett
    Helen K. Tomkinson
    Roger B. Cohen
    BMC Cancer, 17
  • [32] Phase lb study of buparlisib (BKM120) plus either paclitaxel (PTX) in advanced solid tumors (aST) or PTX plus trastuzumab (TZ) in HER2+breast cancer (BC).
    Zambrano, Cristina Cruz
    Schuler, Martin H.
    Machiels, Jean-Pascal H.
    Hess, Dagmar
    Paz-Ares, Luis
    Awada, Ahmad
    von Moos, Roger
    Steeghs, Neeltje
    Ahnert, Jordi Rodon
    De Mesmaeker, Peggy
    Richly, Heike
    Herremans, Catherine
    Joerger, Markus
    Jaime, Jesus Corral
    Alsina, Maria
    Baffert, Fabienne
    Demanse, David
    Duval, Vincent
    Morozov, Alex
    Dirix, Luc
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Phase Ib dose-escalation study of eribulin in combination with capecitabine in patients with advanced/metastatic cancer
    Savulsky, C.
    Nasim, M.
    Plummer, R.
    Evans, J.
    Morrison, R.
    Anthoney, A.
    Haney, S.
    Madi, A.
    Johnston, C.
    Carter, D.
    Reydermann, L.
    Gopalakrishna, P.
    Wanders, J.
    Twelves, C.
    ONKOLOGIE, 2012, 35 : 153 - 154
  • [34] A phase Ia/Ib dose-escalation study of intravenously administered SB 11285 alone and in combination with nivolumab in patients with advanced solid tumors.
    Janku, Filip
    Strauss, James
    Karim, Raghad
    Olszanski, Anthony J.
    Luke, Jason J.
    Leach, Kevin
    Iyer, Radhakrishnan
    Abbas, Atif
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors
    Leong, Stephen
    Moss, Rebecca A.
    Bowles, Daniel W.
    Ware, Joseph A.
    Zhou, Jing
    Spoerke, Jill M.
    Lackner, Mark R.
    Shankar, Geetha
    Schutzman, Jennifer L.
    van der Noll, Ruud
    Voest, Emile E.
    Schellens, Jan H. M.
    ONCOLOGIST, 2017, 22 (12): : 1491 - 1499
  • [36] Phase I dose-escalation study of ON 01910. Na in combination with oxaliplatin in patients with advanced solid tumors
    Chaudhary, I.
    Rajdev, L.
    Swami, U.
    Wilhelm, F.
    Cohen, B.
    Haigentz, M.
    Kaubisch, A.
    Goel, S.
    Mani, S.
    Ghalib, M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Capecitabine (Xeloda®) in combination with oxaliplatin:: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors
    Díaz-Rubio, E
    Evans, TRJ
    Tabernero, J
    Cassidy, J
    Sastre, J
    Eatock, M
    Bisset, D
    Regueiro, P
    Baselga, J
    ANNALS OF ONCOLOGY, 2002, 13 (04) : 558 - 565
  • [38] A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
    Véronique Diéras
    Thomas Bachelot
    Mario Campone
    Nicolas Isambert
    Florence Joly
    Christophe Le Tourneau
    Philippe Cassier
    Emmanuelle Bompas
    Pierre Fumoleau
    Sabine Noal
    Christine Orsini
    Marta Jimenez
    Diane Charlotte Imbs
    Etienne Chatelut
    Oncology and Therapy, 2016, 4 (2) : 211 - 223
  • [39] Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid tumors
    Bendell, JC
    Eder, JP
    Clark, JW
    Fidias, P
    Lynch, TJ
    Seiden, MV
    Ryan, DP
    CANCER, 2005, 103 (09) : 1925 - 1931
  • [40] A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
    Dieras, Veronique
    Bachelot, Thomas
    Campone, Mario
    Isambert, Nicolas
    Joly, Florence
    Le Tourneau, Christophe
    Cassier, Philippe
    Bompas, Emmanuelle
    Fumoleau, Pierre
    Noal, Sabine
    Orsini, Christine
    Jimenez, Marta
    Imbs, Diane Charlotte
    Chatelut, Etienne
    ONCOLOGY AND THERAPY, 2016, 4 (02) : 211 - 223